Perrigo under pressure despite strong rebound in Q2 earnings & cash flow

Perrigo (NYSE:PRGO) Q2 results:

Net sales: $1,219.1M (+6.1%).

Net income: $60.6M (+573.3%); non-GAAP net income: $141.0M (+20.1%); EPS: $0.44 (+528.6%); non-GAAP EPS: $1.03 (+19.8%).

Cash flow ops (6 mo.): $462.7M (+192.3%).

2020 guidance: Net sales growth: 6-7%; organic sales growth: ~3%; non-GAAP EPS: $3.95 – 4.15 (includes $0.12 – 0.15 of COVID-19 costs and a negative $0.06 impact from the divestment of the Rosemont Rx business). Consensus is EPS of $4.07 on revenues of ~$5.2B (+7%).

https://seekingalpha.com/news/3600848-perrigo-under-pressure-despite-strong-rebound-in-q2-earnings-cash-flow